Lundin Gold Inc. (0R4M)
London Stock Exchange · UK · prices in SEK · close of 28 Oct 2026
Key indicators
| Last close | SEK 614.40 |
|---|---|
| 52-week range | 503.00 – 841.06 |
| Return, 1 month / 3 months | +0.6% / +10.8% |
| Return, 1 year / 3 years | +12.9% / +422.0% |
| Trend | Below its 200-day average |
| RSI (14) | 44 |
| Volatility (1 year) | 51.8% |
| Worst drawdown (1 year) | -37.2% |
| Average daily value traded | 1.18M SEK |
| Dividend yield | 26.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Lundin Gold Inc. is a mining company that operates the Fruta del Norte gold mine in southeastern Ecuador. The underground mine produces gold in the form of concentrate and doré bars, which are then shipped to smelters and refineries for further processing. The company is based in Vancouver, Canada, and its business centres on extracting and selling gold from this single South American operation, serving international precious metals markets.
The shares are listed on the London Stock Exchange in UK under the code 0R4M, and the price on this page is in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Lundin Gold Inc. (0R4M) trades on the London Stock Exchange in UK. It last closed at SEK 614.40 on 28 October 2026.
Its price-based Market X-Ray is 50 out of 100 (a weak price profile), ranking 2,086 of 3,789 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 12.9% and over the last three months it rose 10.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 43 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -2.8% | ||
| From 52-week high | -26.5% | ||
| Momentum | 63 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 10.8% | ||
| 6-month return | 1.1% | ||
| 12-month return, skipping the last month | 12.3% | ||
| Stability (higher is calmer) | 30 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 51.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -37.2% | ||
| Liquidity | 55 · Fair | Moderate trading activity. | |
| Average daily value traded | 1.18M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | 71 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 26.6% | ||
| Years with dividends | 5 |
Strengths
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −8.4% |
|---|---|
| 1 month | +0.6% |
| 3 months | +10.8% |
| 6 months | +1.1% |
| 1 year | +12.9% |
| 3 years | +422.0% |
| 5 years | +857.2% |
Signals
| 50-day / 200-day average | 645.81 / 632.24 |
|---|---|
| Golden / death cross (60 days) | Golden, 5 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 19.17 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 9 Sep 2026 | CAD 2.8769 |
| 9 Jun 2026 | CAD 8.3953 |
| 10 Mar 2026 | CAD 7.3604 |
| 4 Dec 2025 | CAD 4.4374 |
| 9 Sep 2025 | CAD 4.3522 |
| 10 Jun 2025 | CAD 1.3631 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.